About MiMedx Group
MiMedx Group, Inc. ("MiMedx Group") is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is successfully emerging from a development-focused start-up phase into a fully integrated operating company with expertise to capitalize on its science and technology and its capacity to generate sales growth and profitability.
"Repair, don't replace" is the mantra of the MiMedx Group biochemists, engineers, and designers who are developing today's biomaterial-based solutions for patients and physicians. Market research shows the first desire of patients ranging from active baby-boomers and weekend warriors to high-school and professional athletes is to augment repair when possible rather than replace traumatized, but otherwise healthy tissues and structures. Clinical research has proven that biomaterials can appropriately work to achieve augmentation and repair.
Our platform technologies, AmnioFix®, EpiFix®, HydroFix® and CollaFix®, have such a vast number of potential applications in treating traumatized tissue and structures that it is too difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all three technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.
AmnioFix®, EpiFix®, HydroFix®and CollaFix®are trademarks of MiMedx Group, Inc.
